This company has shut down. Aristea Therapeutics is no longer operating — its last tracked round was a Series B in 2021.
Explore the Startup GraveyardAristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
Aristea Therapeutics has raised $63.0M in total funding. The most recent round was Series B. The last funding was announced in July 2021.
Aristea Therapeutics's investors include Novo Holdings, Fidelity, Arena Pharmaceuticals, Tekla Capital Management.
Aristea Therapeutics is headquartered in San Diego, United States.
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
Aristea Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aristea Therapeutics — Funding & Investors." VCBacked, July 27, 2021, https://www.vcbacked.co/company/aristea-therapeutics. Accessed September 29, 2026.
VCBacked. (2021). Aristea Therapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/aristea-therapeutics
{{cite web |title=Aristea Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aristea-therapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated